The Food and Drug Administration (FDA) has issued the May Interstate Certified Shellfish Shippers List (ICSSL). The ICSSL is published monthly for the information and use by food control officers, the seafood industry and other interested persons. The shippers listed have been certified by regulatory authorities in the United States, Canada, Chile, Korea, Mexico and New Zealand under the uniform sanitation requirements of the National Shellfish Program.

The Food and Drug Administration issued its weekly Enforcement Report for May 2, 2012, that lists the status of recalls and field corrections for food, drugs, biologics, and devices. The report covers both domestic and foreign firms.

On May 3, 2012, the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On May 2, 2012, the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

During the week of April 24 through April 30, 2012, the Food and Drug Administration modified the following existing Import Alerts on the detention without physical examination of:

On May 1, 2012, the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On April 30, 2012, the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

The Food and Drug Administration recently announced the availability of the following guidance and draft guidances:

The Food and Drug Administration announced that the 15th Annual Education Conference, cosponsored with the Orange Country Regulatory Affairs Discussion Group (OCRA), will be in Irvine, CA, June 6-7, 2012. The conference is intended to give the drug, device, biologics, and dietary supplement industries an opportunity to interact with FDA reviewers and compliance officers from the Centers and District Offices, as well as other industry experts. The FDA said the main focus of the Conference will be product approval, compliance, and risk management in the three medical product areas.

On April 27, 2012, the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of: